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Lantibiotics are potential alternatives to antibiotics because of their broad-range killing
spectrum. The producer strain is immune against its own synthesized lantibiotic via
the expression of two proteins LanI and LanFEG. Recently, gene operons are found in
mainly human pathogenic strains, which confer resistance against lantibiotics. Of all the
lantibiotics discovered till date, nisin produced by some Lactococcus lactis strains is the
most prominent member. Nisin has multiple mode of actions of which binding to the
cell wall precursor lipid II and subsequent insertion into the bacterial membrane to form
pores are the most effective. The nisin producing strains express the lipoprotein NisI to
prevent a suicidal effect. NisI binds nisin, inducing a reversible cell clustering to prevent
nisin from reaching the membrane. Importantly NisI does not modify nisin and releases
it as soon as the concentration in the media drops below a certain level. The human
pathogen Streptococcus agalactiae is naturally resistant against nisin by expressing a
resistance protein called SaNSR, which is a nisin degrading enzyme. By cleaving off
the last six amino acids of nisin, its effectiveness is 100-fold reduced. This cleavage
reaction appears to be specific for nisin since SaNSR recognizes the C-terminal located
lanthionine rings. Recently, the structures of both NisI and SaNSR were determined by
NMR and X-ray crystallography, respectively. Furthermore, for both proteins the binding
site for nisin was determined. Within this review, the structures of both proteins and their
different defense mechanisms are described.
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INTRODUCTION
Since the beginning of the last century, the heterogeneous group of bacteriocins have become
an interesting research topic for various applications like food preservatives or pharmaceutical
purposes as antibiotic alternatives (Cleveland et al., 2001; Cotter et al., 2012). Bacteriocins are
small, ribosomally synthesized peptides of which some possess high antimicrobial activity (Tagg
et al., 1976; Cotter et al., 2005b).
Within the group of bacteriocins a large family exists, which are called lantibiotics (Jung, 1991;
Willey and van der Donk, 2007; Bierbaum and Sahl, 2009; Alvarez-Sieiro et al., 2016). These
are small antimicrobial peptides, which are post-translationally modified and contain uncommon
amino acids (Deyhydrobutyrine or Dehydroalanine). The linkage of these with cysteine residues
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results in the formation of characteristic thioether bridges,
called lanthionine rings. These lanthionine rings ensure
the high antimicrobial activity against various bacteria.
Lantibiotics are highly potent as depicted by the observation that
already nanomolar concentrations are sufficient to fulfill their
antimicrobial activity (Delves-Broughton et al., 1996; Chatterjee
et al., 2005). Furthermore, the lanthionine rings ensure that
lantibiotics are intrinsically resistant against proteolysis by
unspecific degrading enzymes.
Active lantibiotics are able to inhibit the growth of Gram-
positive as well as Gram-negative bacteria. Some exhibit multiple
modes of action, of which binding to lipid II, thereby inhibiting
cell wall synthesis, and pore formation are the most prominent
ones (Héchard and Sahl, 2002; Bierbaum and Sahl, 2009).
Due to the high activitiy in combination with the high
stability lantibiotics are considered as usefull compounds for
medical treatment and food preservatives. One example is nisin
produced by some Lactococcus lactis strains which is linked to
the potential biomedical application against bacterial mastitis,
treatment of methicillin-resistant Staphylococcus aureus (MRSA)
and enterococcal infections. Other examples are the lantibiotics
Gallidermin/Epidermin, which are associated with acne, eczema,
follicultis, impetigo as possible compound for treatment (Cotter
et al., 2005a).
Within the lantibiotic producer strains, the structural genes
for the lantibiotic itself (lanA) as well as for its biosynthesis
and modification (lanBC or lanM), transport (lanT, lanT+C39
peptidase or lanT+C39 peptidase+lanM) across the cellular
membrane are with a few exceptions encoded on a single gene
cluster (Chatterjee et al., 2005; Willey and van der Donk, 2007;
Alkhatib et al., 2012; Singh and Sareen, 2014). Furthermore,
a two-component system (lanK and lanR) is present on this
operon, which up-regulates the expression of these genes
(Kuipers et al., 1995; Qiao et al., 1996).
In order to prevent the harmful effect of the secreted and
activated lantibiotic on their own membrane, additional genes
(lanI and lanFEG) encode a lantibiotic specific (auto-)immunity
system. Interestingly, although lantibiotics are grouped in
different classes based on their size and specific activities (Willey
and van der Donk, 2007; Arnison et al., 2013), the lantibiotic
specific (auto-)immunity system genes seem to be conserved
throughout the species (Alkhatib et al., 2012). The genes of
the (auto-)immunity system encode for the following proteins:
LanI, a membrane associated lipoprotein, and LanFEG, an ABC
transporter localized in the cellular membrane (Draper et al.,
2008, 2015). Some lantibiotic strains contain only one of the
(auto-)immunity proteins, which correlates with the activity of
the produced lantibiotic, which can be membrane binding and/or
pore formation activity.
Nisin secreted by some L. lactis strains is the most prominent
lantibiotic. Due to its high bactericidal activity in combination
with low toxicity in humans, nisin has already been used for
decades as a natural preservative in the food industry (Delves-
Broughton et al., 1996). Active nisin consists of 34 amino acids
and contains five stereo-specifically installed lanthionine-based
rings. The first three rings (rings A–C) are separated from the
last two intertwined rings (rings D–E) by a flexible hinge region
(Van de Ven et al., 1991; Zhou et al., 2015). Rings A and B are
able to bind lipid II, thereby inhibiting cell growth (Hsu et al.,
2004), whereas the hinge region and rings D and E, are able to
flip into the membrane (Wiedemann et al., 2001; van Heusden
et al., 2002; Hasper et al., 2004). This creates pores, which leads to
an immediate eﬄux of nutrients and small compounds, resulting
in cell death (Ruhr and Sahl, 1985; Breukink et al., 1999).
The nisin producing L. lactis strains are immune against
the high antimicrobial activity of nisin via the expression of
an distinct immunity system consisting of the lipoprotein NisI
and ABC transporter NisFEG (Figure 1). When these proteins
are expressed, the producing strains survives a high level of
immunity against nisin, of up to ∼750 nM nisin (1000 IU/ml;
Ra et al., 1996). This concentration is a >100-fold higher than
the 4–6 nM observed in L. lactis strain lacking this immunity
system. Interestingly, both lipoprotein and ABC transporter act
cooperatively and each of them displays only 10–30% of the full
immunity levels when expressed alone (Ra et al., 1999; Stein et al.,
2003; AlKhatib et al., 2014a,b).
Such an (auto)-immunity system is conserved and present
in al most all lantibiotic producing strain. For example, the
subtilin producing Bacillus subtilis strain expresses SpaI and
SpaFEG (Klein and Entian, 1994); the epidermin producer
Staphylococcus epidermidis expresses EpiH and EpiFEG (Peschel
and Götz, 1996; Otto et al., 1998); the gallidermin producer
Staphylococcus gallinarium expresses GdmH and GdmFEG and
the Pep5 producer S. epidermidis expresses PepI (Reis et al., 1994).
More examples as well as their operon structure are highlighted
in (Alkhatib et al., 2012).
Recently, however, some operons were described encoding
a protein defense system against lantibiotics although the host
strain is not producing these lantibiotics itself. Interestingly,
these operon are mainly found in human pathogenic strains.
The expression of the genes localized on these operon results in
a resistance against the lantibiotic. For example: lctGEFlcrXRS
in Streptococcus mutans conferring resistance against nisin,
nukacin ISK-I and lacticin 481 (Kawada-Matsuo et al., 2013),
and graXSR/vraFG in S. aureus provides resistance against
various lantibiotics including nisin and nukacin ISK-I (Meehl
et al., 2007; Falord et al., 2011, 2012). The cprABCK-R
operon from Clostridium difficile confers even resistance against
multiple lantibiotics of which nisin, gallidermin, subtilin, and
mutacin 1140 (McBride and Sonenshein, 2011; Suárez et al.,
2013).
In Streptococcus agalactiae, the operon identified confers
resistance against the lantibiotic nisin and resembles the genetic
architecture of the nisI and nisFEG immunity genes found in
the producing L. lactis strain (Khosa et al., 2013; Figure 1). The
genes encoded on this operon are called nsr (encoding for nisin
resistance protein) and nsrFP (encoding for an ABC transporter),
which are probably auto-regulated by a two-component system
formed by nsrR and nsrK (Khosa et al., 2013). The solely
expressed membrane-associated nisin resistance protein (also
known as NSR) has been shown to confer 20-fold resistance
against nisin, when expressed in a sensitive L. lactis strain
(Khosa et al., 2013). Due to the high sequence homology of
NSR, especially the specific TASSAEM region, homologs of this
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FIGURE 1 | Schematic representation of the nisin (auto-)immunity and resistance system. Both systems comprise of a lipoprotein/membrane-associated
protein (colored in red/pink, respectively), an ABC transporter (depicted in blue) and a two-component system (shown in green). Functionally similar genes are color
coded identically with the exception of NisI and NSR.
resistance protein have been identified in several other strains
such as S. epidermidis among others (Khosa et al., 2013).
Recently, the structures of both nisin (auto-)immunity protein
NisI from L. lactis (Hacker et al., 2015) as well as the resistance
protein NSR from S. agalactiae (SaNSR; Khosa et al., 2016)
have been revealed. They both, although sharing a low sequence
similarity of only 23%, protect the cell membrane against the
presence of high concentrations of nisin albeit by a different
mechanism. Both proteins can be considered as role models for
the (auto-)immunity and resistance system of other lantibiotics.
Within this review, the function and structure of both proteins
will be compared and described.
THE NISIN IMMUNITY PROTEIN NisI
In nisin producing L. lactis strains, the LanI immunity protein
is called NisI, which is a 27.8 kDa in size comprising of 245
amino acid residues (Kuipers et al., 1993; Table 1). The sequence
contains a signal peptide which is cleaved off after secretion
followed by a site for lipidation (Cys-1 in mature NisI; Kuipers
et al., 1993; Sutcliffe and Russell, 1995). The resulting mature NisI
(226 amino acid residues and 25.8 kDa in size) is lipid-anchored
at the outside of the cytoplasmic membrane (Ra et al., 1996).
Approximately, one-third of NisI escapes this lipid modification
and is thereby released into the extracellular environment in a
lipid-free form that forms an additional mechanism of immunity
(Koponen et al., 2004; Takala et al., 2004).
NisI exhibits two functions preventing nisin to reach the
cellular membrane. First NisI binds nisin, thereby protecting
the nisin-producing bacteria. Important, here is the fact that
NisI does not modify or degrade nisin as shown by several
independent studies (Qiao et al., 1995; Ra et al., 1996, 1999;
Stein et al., 2003; Koponen et al., 2004; AlKhatib et al., 2014a).
Initially, the involvement of NisI in immunity was identified via
the expression of solely NisI which increased the nisin resistance
of both E. coli and L. lactis (Kuipers et al., 1993). Furthermore, the
significance of NisI in the overall nisin immunity of L. lactis cells
was observed via deletion of the nisI gene within the whole nisin
operon. The resulting nisI knockout strain was more sensitive to
nisin than the fully equipped L. lactis strain (Siegers and Entian,
1995). Interestingly, the knockout strain of the nisI gene had
more adverse effects than the knockout of the nisFEG genes,
leading to the hypothesis that the NisI protein plays a more
effective role in the immunity against nisin.
In order to obtain further information on the functioning
of the nisI gene, it was expressed in a nisin-sensitive L. lactis
NZ900 strain that contains the nisRK two-component system but
lacks the rest of the nisin operon and especially the immunity
system encoding genes. When NisI was expressed in this strain,
8–10-fold more nisin was needed to inhibit the cell growth by
50% (IC50; AlKhatib et al., 2014a; Figure 2A). Various studies
have shown the importance of the C-terminus of NisI for its
activity, especially the last 22 amino acids (Takala and Saris,
2006; AlKhatib et al., 2014a). A deletion of the last 22 residues,
reduces the activity of NisI to 30–34% (AlKhatib et al., 2014a).
Furthermore, a deletion of only the last five residues decreases
the immunity conferred by NisI to approximately 78% (Takala
and Saris, 2006). It appears that at low nisin concentration in the
environment, the binding capacity of NisI is enough to provide
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TABLE 1 | Characteristics of the nisin immunity protein NisI and nisin
resistance protein NSR (∗ IC50 compared against sensitive Lactococcus
lactis strain NZ9000; Sun et al., 2009; AlKhatib et al., 2014a; Hacker et al.,
2015; Khosa et al., 2016).
NisI SaNSR
Sequence length 245 320
Molecular weight (kDa) 27.8 (full-length)/25.8
(processed)
36.2
Localization Membrane
attached/lipid-free
Membrane spanning
Sequence motif N-terminal signal
peptide
N-terminal
transmembrane
helix/conserved
TASSAEM region
Function Nisin binding Nisin cleavage
Observed mechanism Reversible cell
clustering
Nisin proteolysis
Substrate specificity N-terminus of nisin:
rings A and B
C-terminus of nisin:
rings D and E + last six
amino acids
Conferred
Immunity/resistance ∗
8–10-fold 18–20-fold
Important residues Tyr152, Asp155 His98, Ser236
Binding affinity 1 µM Not determined
Structure determined NMR X-ray crystallography
Structure Mainly β-sheet: two
domains and a flexible
linker
Helical bundle,
protease fold, protease
core domain
Binding site determined NMR/mutational
studies
Molecular dynamic
simulations/mutational
studies
immunity up to a concentration of 60 nM, where the cells are
still able to grow. Since the immunity conferred by NisI is a
result of its binding to nisin, it is somewhat surprising that NisI
in vitro displayed a rather weak affinity for nisin as seen by a KD
of approximately 0.6–2 µM (Takala et al., 2004; Hacker et al.,
2015). However, this is likely due to the fact that the in vitro
experimental setup lacks the membrane environment.
Recently, in addition to the binding capability of NisI, a second
mechanism for conferring immunity by NisI was also described.
Upon addition of nisin to nisI expressing L. lactis cells, the
cells start to cluster. Especially at nisin concentrations above the
determined IC50 value, the cells cluster to form large chains up
to a number of 30 cells (AlKhatib et al., 2014a). Importantly,
this clustering is only observed when both NisI and nisin are
present. Due to this clustering, nisin is unable to reach lipid II.
Thereby the activity of nisin, especially the pore forming ability is
inhibited as observed via a so-called Sytox assay (AlKhatib et al.,
2014a). This clustering mechanism is reversible and as soon as
the the external nisin concentration drops below the IC50 value,
the L. lactis cells start growing normally again (AlKhatib et al.,
2014a). Thus, when the concentration of nisin increases above
a certain threshold (in the reported study around 60–70 nM),
which coincides with the measured IC50 values, the presence of
both NisI and nisin induces a clustering of the L. lactis cells.
In the nisin sensitive strains lacking nisI or upon expressing a
nisI variant lacking the C-terminally located 22 amino acids, this
clustering is not observed, leading to the assumption that the
C-terminus of NisI is responsible for this clustering phenomenon
(AlKhatib et al., 2014a). This is inline with studies describing
that the C-terminus of NisI (last 21 amino acids) interacts with
nisin and provides specificity to NisI (Takala and Saris, 2006).
Although, this clustering is an interesting observation it has not
been unraveled how NisI mediates this.
Since the first two rings of nisin (N-terminal region) are
crucial for its binding to lipid II (Wiedemann et al., 2001), which
is an initial step in the activity of nisin and also essential for
pore formation by nisin, it is a reasonable assumption that NisI
recognizes the N-terminus of nisin, presumably the first two
rings. Thereby, NisI would directly interfere with the initial and
crucial binding event of nisin with lipid II.
THE NISIN RESISTANCE PROTEIN
SaNSR
The counter part of NisI in the nisin resistance system of
S. agalactiae is the nisin resistance protein (SaNSR), which
contains 320 amino acids and has a molecular weight of 36.2 kDa
(Froseth and McKAY, 1991; Khosa et al., 2013; Table 1). SaNSR
has a N-terminus hydrophobic region predicted to encode a
transmembrane helix (Khosa et al., 2013), thereby SaNSR would
be localized at the bacterial membrane (Sun et al., 2009).
SaNSR is a nisin degrading enzyme (Sun et al., 2009). Since
the lanthionine rings usually cause steric hindrance, thereby
inhibiting any protease cleavage a nisin degradation mechanism
is quite unique (Wiedemann et al., 2001). SaNSR cleaves off the
last six amino acids of nisin, yielding two fragments: nisin1−28
and nisin29−34. This nisin1−28 variant when purified displays
100-fold less bactericidal activity and significantly less affinity
toward the bacterial membrane (Sun et al., 2009; AlKhatib et al.,
2014a). Thus, the non-producing strains become resistant against
nisin by reducing its effectiveness. SaNSR confers 18–20-fold
resistance in a nisin sensitive L. lactis strain as determined by
IC50 assays (Figure 2B). SaNSR belongs to the S41 family of
peptidases and contains a highly conserved TASSAEM sequence
motif, which harbors the catalytically active serine residue at
position 236 (Table 1; Khosa et al., 2013, 2016). This 18–20-fold
resistance mediated by SaNSR when expressed in nisin sensitive
L. lactis cells is almost lost when mutating this Ser236 residue
(Khosa et al., 2013).
Furthermore, the resistance mediated by SaNSR in nisin
sensitive L. lactis strain dropped to mere 1.4–1.7-fold for the
nisin variants lacking the rings D and E or only E (Khosa et al.,
2016). Additionally, removing the last 6 or 12 amino acids of nisin
(nisin1−28 and nisin1−22, respectively) completely abolished the
resistance, clearly indicating the importance of the last ring as
well as the C-terminal tail of nisin for recognition by SaNSR.
This is in contrast to the specificity of NisI. Nisin shares a high
sequence similarity of around 63% with subtilin from B. subtilis,
and like nisin the lantibiotic subtilomycin also harbors five
lanthionine-based rings (Barbosa et al., 2015). Therefore, it might
be possible that SaNSR exhibit a broader substrate specificity
including resistance toward other lantibiotics as well. Such a
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FIGURE 2 | Activity determination of NisI and SaNSR. The IC50 value was determined for the nisin sensitive Lactococcus lactis NZ9000 strain (black) in
comparison with the same strain harboring a plasmid containing the nisI (A; shown in blue) or nsr (B; shown in pink) gene.
multiple lantibiotic resistance specificity has been previously
described for an other lantibiotic resistance operon system of
C. difficile (McBride and Sonenshein, 2011; Suárez et al., 2013).
STRUCTURES OF THE IMMUNITY
PROTEIN NisI AND THE RESISTANCE
PROTEIN NSR
The structure of NisI from L. lactis was solved using NMR
spectroscopy (Hacker et al., 2015). NisI is a two-domain and
predominantly a β-sheet containing protein (Figure 3A). The
N-terminal part (1–111 residues) is connected to the C-terminal
domain (120–226) via a flexible linker (112–119). Interestingly
and rather unusual is that both domains adopt a similar unique
fold, which has been previously observed for SpaI from B. subtilis,
the immunity protein against subtilin (Christ et al., 2012). The
core of the N- and C- terminal domains of NisI are formed by
a seven-stranded antiparallel twisted β-sheet in the strand order
β1-β2-β3-β8-β7-β6b-β4a. An extended β-hairpin is formed by
strands β4b and β6a that is stabilized by hydrophobic packing
interactions with residues from β1 and β2. In addition, the
β-hairpin is flanked by a short 310 helix.
NisI lacks the N-terminus unstructured region, which is
present in SpaI and supposedly allows interaction with the host
membrane (Christ et al., 2012; Hacker et al., 2015). Since it was
proposed that NisI interacts with the membrane, an elegant set of
experiments were performed with the single expressed domains,
which revealed that only the N-terminal domain possesses
affinity toward the membrane environment (Hacker et al., 2015;
Figure 4). Therefore, this domain is thought to be localized at
the membrane surface. On the contrary, the C-terminal domain
of NisI does not bind to lipids. Instead this C-terminal domain
binds nisin as observed in NMR titration experiments. This
is inline with the previous observations that the C-terminally
located last 22 amino acids are important for the functioning
of NisI in vivo. Although structurally similar, both domains
of NisI differ in their surface properties. While the surface of
the N-terminal domain of NisI is highly positively charged and
interacts with membranes, the C-terminal domain has negatively
charged surface with hydrophobic patches and is able to bind
nisin (Figure 4A), thereby modulating the membrane affinity
of the N-terminal domain of NisI by shielding its membrane
binding surface (Hacker et al., 2015; Figure 4A). NisI has not
been shown to interact with other lantibiotics and displays rather
high substrate specificity. A protein consisting of the N-terminal
SpaI domain fused to the C-terminal domain of NisI, however,
displays immunity against nisin (Takala and Saris, 2006). This
highlights that the nisin binding site is localized within the
C-terminus of NisI. Since subtilin and nisin share high homology
in terms of sequence as well as lanthioinine ring positions it
is not surprising that the domain structure of NisI and SpaI
are structurally similar. This in contrast to the structure MlbQ
from the actinomycete Microbispora ATCC PTA-5024 conferring
resistance against NAI-107 which was solved by NMR (Pozzi
et al., 2015). No significant sequence identity as well as structural
similarity was observed between NisI and MlbQ. This likely is due
to the larger difference between nisin and NAI-107 in sequence
as well as lanthionine ring composition. It seems that the LanI
immunity proteins evolved differently and are highly specific for
their cognate lantibiotic.
The crystal structure of nisin resistance protein from
S. agalactiae (SaNSR; without the N-terminal transmembrane
helix) was solved using X-ray crystallography and consists of
eleven α-helices and eleven β-strands (Figure 3B; Khosa et al.,
2016). SaNSR is composed of three domains: an N-terminal
helical bundle comprising of 65 amino acid residues (Lys31-
Gly96), form helices α1-α3. This domain ends in a triple glycine
motif before entering the protease cap domain. This protease cap
domain consists of helix α4 and a β-hairpin structure formed
by two strands and forms a lid-like structure above the tunnel.
The last domain called the protease core is formed by six
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FIGURE 3 | Cartoon representation of the structures of NisI and SaNSR. The structures of (A) NisI (PDB codes: 2N32 and 2N2E) and (B) SaNSR (PDB code:
4Y68) are shown with the secondary elements color coded as red for helices, yellow for sheets and green for the loops. The figure was created with Pymol.
FIGURE 4 | Electrostatic surface potential of the structures of NisI and SaNSR. The electrostatic surface potential of (A) NisI (PDB codes: 2N32 and 2N2E)
and (B) SaNSR (PDB code: 4Y68) structures is shown. Negatively charged surface areas are colored in red, while the positively charged areas colored in blue and
white areas correspond to hydrophobic surfaces. The determined nisin binding site for both proteins are highlighted with a green line. The figure was created with
Pymol.
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strands βb-βg and five helices α5-α9 and adopts a ‘protease
fold’ domain as observed in other S41 peptidases (Liao et al.,
2000; Kim et al., 2002; Mastny et al., 2013). Together they
form a hydrophobic tunnel of ∼10 Å width. This hydrophobic,
negatively charged tunnel is responsible for binding to nisin by
‘roping in’ the peptide (Figure 4B). The protease core domain
also contains the highly conserved TASSAEM region that harbors
the previously identified catalytically active serine at position 236
(Khosa et al., 2013).
The active center of SaNSR consists of a catalytic dyad
formed by residues Ser236 (Khosa et al., 2013), which is part of
the TASSAEM motif, and His98 as determined by mutational
analysis (Khosa et al., 2016) and also described for some other
proteases (Page and Di Cera, 2008).
Unfortunately, the crystal structure lacks the substrate nisin.
Instead a peptide called N-pep, belonging to symmetry-related
molecule was bound within the tunnel. This information was
used for molecular dynamic simulation studies to determine
the nisin-binding site. It was observed that nisin is stably
bound in the tunnel formed in between the domains of SaNSR.
Additionally, the residues forming the hydrophobic interactions
for proper orientation of rings D and E of nisin are embedded in
the protease core domain within or on the outside of the tunnel
that is situated in the middle of SaNSR protein.
The model of SaNSR/nisin complex demonstrates the
significance of C-terminally located lanthionine rings D and E
of nisin for substrate specificity (Wiedemann et al., 2001). The
importance of these rings was also highlighted by mutational
analyses of nisin. Here, SaNSR did not recognize nisin variants
lacking the last or the last two rings.
CONCLUSION
The expression of NisI and NSR reduce the activity of nisin. In the
nisin producing strains, the immunity protein NisI solely binds
nisin thereby reducing the amount of nisin reaching the lipid II
target molecule in the membrane. To achieve this NisI not only
binds to nisin but also induces a “shielding mechanism” of the
L. lactis cells. Immunity is thereby provided without harming or
modifying the own lantibiotic produced.
In contrast, NSR present in nisin non-producing strains
cleaves nisin in two parts, thus, reducing the ability of nisin to
form pores in the membrane.
NisI and NSR, however, represent the first line of defense
and within both immunity and the resistance operons, an
additional protein system is also encoded. In case of the
immunity system, it is the ABC transporter NisFEG and for
the resistance system, it is NsrFP. It has been shown that
NisFEG and NisI act cooperatively. However, for the nsr
system such a cooperative mechanism has not been detected
so far and it has to be further investigated whether these
resistance proteins are also able to act together in their
battle against the lantibiotic nisin. Although, lantibiotics are
considered to be powerfull biological antimicrobial compounds
already resistance mechanisms are present in some human
pathogenic strains. This hampers the usage of lantibiotics for
medical purposes. A detailed knowledge about these resistance
mechanisms would pave a way to bypass these inherently present
systems.
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